Table 2 Clinical characteristics of patients

From: Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model

    

Gleason

 

PSA at diagnosis

PSA nadir

ID

Age

Ethnicity

Race

Score

TNM stage

ng/mL

ng/mL

UM10001

67

NH

C

9

T4N1M1

2.40

0.32

UM10003

53

NH

C

9

TxNxM1

114.10

<0.01

UM10029

62

NH

C

7

TxNxMx

7.96

0.1

UM10035

61

NH

C

9

T2N1M0

9.48

<0.01

UM10055

62

NH

C

7

TxN1Mx

9.20

0.1

UM10099

59

NH

B

9

TxNxMx

285.70

10.8

  1. NH Non-Hispanic, C Caucasian, B Black.